MABp1 IN HIDRADENITIS SUPPURATIVA REFRACTORY TO ADALIMUMAB

Clinical Trial ID NCT02643654

PubWeight™ 0.93‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02643654

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment. Br J Dermatol 2014 1.63
2 Safety and Efficacy of Anakinra in Severe Hidradenitis Suppurativa: A Randomized Clinical Trial. JAMA Dermatol 2016 0.93
3 Compartmentalized Cytokine Responses in Hidradenitis Suppurativa. PLoS One 2015 0.81
4 Ultrasound aids in diagnosis and severity assessment of hidradenitis suppurativa. Br J Dermatol 2010 0.78
Next 100